☀ Trending Among Corona Carnage ☀ List of Best Performing Corona Vaccine Stocks, Tech Penny Stocks, Healthcare Stocks, and Artificial Intelligence Stocks. Medicines, drugs and medical devices have been the basic need of human population. The pharma industry aims to serve this fundamental need, by the discovery, production and marketing of the drugs that are aimed to prevent the diseases or offer treatment of the diseases to the mankind. Large and small pharma companies are running across the globe to produce drugs and other related pharma products, and lots of them have their stocks listed on the stock exchanges worldwide. This allows for a good opportunity to common investors and traders to benefit from the pharma business. However, one must note that the pharma industry is heavily regulated, and approval or rejection of drugs, patent validity, factory conditions, competitor developments, and similar related parameters decide the fortune of the pharma companies. Among the several pharma companies whose stocks are actively trading on the stock exchanges, which have been the winners in terms of highest returns? This article provides a list of pharma stocks which have generated the highest returns in the year 2021 till date of writing. The list is prepared based on the percentage returns generated by the individual pharma stocks between the end of the previous and Jul 12, 2021, and the top 10 return generating pharma stocks are listed below.
Best Performing Stock Screener:
This page is updated every week/month. Bookmark this site to track the best performing stocks regularly.
The following list presents stocks of the companies which belong to the broader Pharma sector or the stock market index, their corresponding prices as of given date, and the percentage gains realized: 1) Immunome, Inc. (IMNM)
Here's a look at the basic details and how the above mentioned stocks fared during the period:
Immunome Inc., a biotechnology company, discovers, develops, and commercializes highly targeted and native human cancer antibodies against ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Immunome, Inc.. The Exton, United States-headquartered company Immunome, Inc. (IMNM) is ranked number one among the best performing stocks of Pharma of 2021. The Healthcare sector business falls under the Biotechnology industrial sub-sector. Since the start of the year 2021, the stock price of Immunome, Inc. has changed by 74.9 percent, which is calculated based on the previous year's closing price of $9.68 per share and year-to-date closing price of $16.93 per share as of writing. The market value of the company as indicated by its market-cap changed from $102.04 million to $199.05 million during the same period. Along with Pharma, the company is also in the business of Health Care, Major Pharmaceuticals, Biotechnology, Biotech, Healthcare, among other usual products and services.
Catalyst Pharmaceuticals, Inc., formerly Catalyst Pharmaceutical Partners, Inc., incorporated on July 21, 2006, is a development-stage biopharmaceutical company. The Company is focused on developing and commercializing therapies for people with ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Catalyst Pharma. The Florida, FL-based Healthcare sector company Catalyst Pharmaceuticals, Inc. (CPRX) holds the number two spot among the best performing stocks of the Pharma sector. Classified as the Major Pharmaceuticals business, the stock price of Catalyst Pharma ended the previous year at a price of $3.34 per share while it reached the level of $5.61 apiece as of Jul 12, 2021 translating to a percentage change in stock price of 67.96%. As of writing, the company's market-cap value stands at $594.24 million. Few leading stock market index includes Catalyst Pharma in their constituent list. They include Wilshire 5000 index, and a few other larger indexes which are part of the stock market.
Vanda Pharmaceuticals Inc., incorporated on November 13, 2002, is a biopharmaceutical company. The Company is focused on the development and commercialization of therapies to address unmet medical needs. Its product ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Vanda Pharma. During the given months of the year 2021, Vanda Pharmaceuticals Inc. (VNDA) was successful in generating YTD returns of 51.45 percentage which helped it gain the number three spot in the list of the top performing stocks which generated maximum returns during year 2021 till date. As of December of the previous year, the stock of the Maryland, MD-based Vanda Pharma closed at a price of $13.14 per share, while it traded at a price of $19.9 per share as of Jul 12, 2021. The company's market cap changed from $718.65 million to $1.11 billion during the same period YTD. It ranks as a key constituent of major indexes that include Wilshire 5000 index, and several other broader level multi-cap market indicators.
The company is classified under the Healthcare industry sector and further specialized as a Major Pharmaceuticals sector business.
Prestige Brands Holdings, Inc., incorporated on June 24, 2004, is engaged in the marketing, sales and distribution of over-the-counter healthcare and household cleaning products to mass merchandisers, drug stores, supermarkets, ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Prestige Brand. The New York, NY-based Prestige Brand Holdings, Inc. (PBH) belongs to the Healthcare sector and is categorized as a Major Pharmaceuticals company. The stock of Prestige Brand ended the previous year at a price of $34.87 per share. As of Jul 12, 2021, the stock price has reached $51.96 apiece, which indicates a change of 49.01 percent making the company rank among the top performing stocks of the Pharma for the year 2021 till date. At the end of the last year, company's market capitalization stood at $1.75 billion. It has now changed to $2.6 billion as of writing. Prestige Brand continues to be a leading constituent of many major stock market indexes like Wilshire 5000 index, and several other broader level multi-cap market indicators.
Biogen Inc., incorporated on April 1, 1997, is a biopharmaceutical company. The Company focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Biogen. Rank number five in the coveted list is held by Biogen Inc. (BIIB) for being among the top performing stocks of 2021. Headquartered in Weston, Massachusetts, the Healthcare sector company is categorized under the industrial sub-sector of Biotech Biological Products. Since the start of the year 2021, stock of Biogen has so far gained 42.55 percentage, based on the previous year's closing price of $244.86 per share and year-to-date price of $349.04 per share. During the same period, the market capitalization of the company changed from $37.68 billion to $52.55 billion. The stock of Biogen continues to be a major constituent of many leading stock indexes which include NASDAQ 100 index, Wilshire 5000 index, S&P 500 index, and several other broader level multi-cap market indicators.
Bausch Health Companies
Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter products primarily in the therapeutic areas of eye health, gastroenterology, and ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Bausch Health Companies. At number six in the list of top stocks stands Bausch Health Companies Inc. (BHC), which saw a change in its stock price from the level of $20.8 apiece during previous year December end to the price of $29.6 per share as of Jul 12, 2021. It translates to a change of 42.31 percentage. The Laval, QC-headquartered Healthcare sector company also saw its market value change from $7.33 billion to $10.61 billion.
Cerevel Therapeutics Holdings,
Cerevel Therapeutics Holdings, Inc. operates as a clinical-stage biopharmaceutical company that engages in the development of various therapies ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Cerevel Therapeutics Holdings, . Cerevel Therapeutics Holdings, Inc. (CERE) has moved by 41.98 percentage over the given period of 2021-YTD, helping it gain a place at number seven among the top performing stocks. The Healthcare sector company managed to achieve the feat as its stock price changed from $16.58 apiece to the price of $23.54 per share between the end of December of the previous year and Jul 12, 2021. The smart run of the Cambridge, United States-based Biotechnology sector company lead to a handsome gain in its marketcap which changed from $2.11 billion to $3 billion over the same duration.
Maravai LifeSciences Holdings,
Maravai LifeSciences Holdings, Inc. operates as a life sciences company that provides products to enable the development of drug therapies, ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Maravai LifeSciences Holdings, . Based on the market-cap change from $7.01 billion to $10.34 billion during the given months of the year 2021 and the share price change from $28.05 per share to a price of $39.39 per share as of Jul 12, 2021, Maravai LifeSciences Holdings, Inc. (MRVI) was successful in generating YTD returns of 40.43 percentage. Standing at the number eight rank in the top performing list of Pharma stocks, the San Diego, United States-based Maravai LifeSciences Holdings, is categorized as the Biotechnology sub-sector business which falls under the larger Healthcare sector.
Eli Lilly and Company, incorporated on January 17, 1901, is engaged in drug manufacturing business. The Company discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Eli Lilly. Eli Lilly (LLY) generated percentage returns of 39.78 percent during the 2021 year-to-date. Its returns are based on the share price which moved from $168.84 per share from the previous year-end to the price of $236.01 per share as of Jul 12, 2021. The company's value, as indicated by the market-cap figure, changed from $161.51 billion to $226.34 billion during the same period. The company is categorized as a Healthcare speciality business with further classification in the Major Pharmaceuticals sub-category. Based in Indianapolis, Indiana, the YTD performance of the Pharma sector also fared better than that of the returns generated by some of the closley tracked stock market indexes. The company is a part of Wilshire 5000 index, S&P 500 index, and a few other wider multi-cap stock market indexes.
Phibro Animal Health
Phibro Animal Health Corporation (Phibro), incorporated on January 27, 2014, is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Phibro Animal Health. The number ten spot in the list of top performing stocks of the Pharma sector is taken by Phibro Animal Health Corporation (PAHC). The company's stock price changed from $19.42 per share at the end of December of the previous year to the price of $27.14 per share as of writing. Overall, the stock managed to realized price change of 39.75 percent during the given time period. The corresponding change in the market capitalization value of the New Jersey, NJ-based Healthcare sector company was from $785.61 million to $1.12 billion. Being ranked in the top 10 best performing stocks of the Pharma sector, the company also succeeded in outperforming the returns generated by some of the popular stock market indexes. They include the Wilshire 5000 index, and a handful of other multi-capitalization indexes.This page is updated every week/month. Bookmark this site to track the best performing stocks regularly.